Embecta Corp (EMBC)

NASD · Healthcare · Medical Instruments & Supplies · USA

Embecta Corp is a small cap company (market value between $300 million and $2 billion) in the Medical Instruments & Supplies industry.

Intrinsic value, DCF valuation, financial health and value investing analysis for the Embecta Corp stock.

Our verdict on EMBC

No reliable verdict: intrinsic value $48.64 per share, market price $6.15 (as of 2026-11-17).

Discounting its cash flows would put the shares at $48.64: 8 times the price of $6.15. A gap that size says more about a model than about the market. It usually means heavy debt, where a small error in the value of the business becomes a large one in the value of the shares, or a business our method does not describe. We do not publish a verdict on this one.

ETFs with the most weight in EMBC

17 more funds hold it; the full list is part of the paid plan.

Browse

Peers in Medical Instruments & Supplies

All 52 Medical Instruments & Supplies stocks

Is EMBC undervalued or overvalued?

We do not publish a verdict on EMBC. Discounting its cash flows would put the shares at $48.64: 8 times the price of $6.15. A gap that size says more about a model than about the market. It usually means heavy debt, where a small error in the value of the business becomes a large one in the value of the shares, or a business our method does not describe. We do not publish a verdict on this one.

What is the intrinsic value of EMBC?

We do not publish one (as of the 2026-11-17 close). Discounting its cash flows would put the shares at $48.64: 8 times the price of $6.15. A gap that size says more about a model than about the market. It usually means heavy debt, where a small error in the value of the business becomes a large one in the value of the shares, or a business our method does not describe. We do not publish a verdict on this one.